Cilostazol for Secondary Prevention of Stroke: Should the Guidelines Perhaps Be Extended? - Wikidata - awgldk - TriplyDB

Cilostazol for Secondary Prevention of Stroke: Should the Guidelines Perhaps Be Extended?

Cilostazol for Secondary Prevention of Stroke: Should the Guidelines Perhaps Be Extended?

http://www.wikidata.org/entity/Q41658499

about

Cilostazol for Secondary Prevention of Stroke: Should the Guidelines Perhaps Be Extended?

http://www.wikidata.org/entity/Q41658499

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Cilostazol for Secondary Prevention of Stroke: Should the Guidelines Perhaps Be Extended?

@en

type

label

Cilostazol for Secondary Prevention of Stroke: Should the Guidelines Perhaps Be Extended?

@en

prefLabel

Cilostazol for Secondary Prevention of Stroke: Should the Guidelines Perhaps Be Extended?

@en

P1433

Q41658499-965EF485-212E-4FAC-923E-3DC7D355DD4C

P1476

Q41658499-3BCAC72C-420D-4D97-829A-E1AC525B6432

P2093

Q41658499-5700845D-5294-4593-9402-BAFD61FEFDD9

P2860

Q41658499-04E7F78E-F735-4DEF-9E72-44EBE7F80B2D

Q41658499-0C19ABC1-23C5-4B8B-A978-E970A1932550

Q41658499-156670E8-77C9-4E53-911F-A2B2F3B8B5B3

Q41658499-185D55C3-36C9-47B4-AE73-9987F53FF03F

Q41658499-2271ECAB-11F5-4BE1-9DB9-4E81D8904A90

Q41658499-2E2B0D40-47E3-4448-BD65-F36BBB912F0D

Q41658499-38A42E53-DE59-43ED-90AB-655F283281A3

Q41658499-3B2272DE-6D83-46A1-A1EC-D4D72E003228

Q41658499-4916C5D0-EBBB-455F-9136-CDCBEDEDC48D

Q41658499-4A79123D-A00E-406D-B861-0CBA42356083

P304

Q41658499-1FF478B9-F783-4FB9-8FB6-BC740C9B8BF2

P31

Q41658499-1692C8F0-19B9-4596-9051-EC899994A4CC

P356

Q41658499-20DBA473-7034-4E1E-8BE2-DCB5FFF44202

P433

Q41658499-C97C326B-335C-4A0A-95FF-29C6666FFD68

P478

Q41658499-85DE98C8-9541-44EC-90E3-257D3E25D24D

P50

Q41658499-BCB83B15-FCB9-4572-8DC9-E5E200EB306B

P577

Q41658499-A371150F-1272-4AF2-B60A-80B0F3F31916

P698

Q41658499-6DAF12DC-C63C-4FD6-8698-0F0BFFFBABD6

P932

Q41658499-79BED9FC-72E5-4368-BF5D-B14D83E6ACCD

P356

VSI.2017.33.3.89

P1433

Vascular specialist international

P1476

Cilostazol for Secondary Prevention of Stroke: Should the Guidelines Perhaps Be Extended?

@en

P2093

Argyri Sianou

http://www.w3.org/2001/XMLSchema#string

P2860

Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

Cilostazol versus aspirin for secondary prevention of vascular events after stroke of arterial origin

Protective effects of cilostazol against hemorrhagic stroke: Current and future perspectives

Long-Term Antiplatelet Mono- and Dual Therapies After Ischemic Stroke or Transient Ischemic Attack: Network Meta-Analysis

Antiplatelet regimens in the long-term secondary prevention of transient ischaemic attack and ischaemic stroke: an updated network meta-analysis

A randomized crossover comparative study of aspirin, cilostazol and clopidogrel in normal controls: analysis with quantitative bleeding time and platelet aggregation test

Cyclic AMP inhibited proliferation of human aortic vascular smooth muscle cells, accompanied by induction of p53 and p21

Cilostazol inhibits accumulation of triglyceride in aorta and platelet aggregation in cholesterol-fed rabbits

Molecular mechanisms of decreased smooth muscle differentiation marker expression after vascular injury.

Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA Guideline Recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

P304

89-92

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5758/VSI.2017.33.3.89

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-09-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28955697

http://www.w3.org/2001/XMLSchema#string

P932

5614376

http://www.w3.org/2001/XMLSchema#string